Rheumatoid arthritis (refractory) - abatacept
Abatacept for the treatment of rheumatoid arthritis (TA141)
Chapter :
1. Guidance
1.1. Abatacept is not recommended (within its marketing authorisation) for the treatment of people with rheumatoid arthritis.
1.2. Patients currently receiving abatacept for the treatment of rheumatoid arthritis should have the option to continue therapy until they and their clinicians consider it appropriate to stop.
